Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FJLFA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $96,926
Award facts
- Contract value 100% obligated
- $96,926.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $96,926.16 by the Defense Logistics Agency (DLA) on September 12, 2025. The contract covers the supply of Stelara 90 mg/ml syringes, a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and Crohn's disease. This delivery order is a firm fixed-price contract with an ultimate completion date of October 3, 2025, and represents no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal marketplace based on its capabilities as a woman-owned small business.
This award is issued as a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.9 million and valid through November 2026. The parent IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards for branded and generic prescription drugs, biologics, and medical consumables distributed to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FJLFA?
SPE2DB25FJLFA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FJLFA worth?
The government has obligated $96,926 on SPE2DB25FJLFA.
Is contract SPE2DB25FJLFA an order under another contract?
Yes. SPE2DB25FJLFA is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLFA competed?
The extent of competition for SPE2DB25FJLFA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award